Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

XOB

From Wikipedia, the free encyclopedia
Pharmaceutical compound
XOB
Clinical data
Other namesASR-6001; ASR6001;N-[(4-Phenylbutoxy)hexyl]-4-bromo-2,5-dimethoxyphenethylamine
Drug classSerotonin5-HT2A receptorantagonist;Voltage-gated sodium channelblocker
ATC code
  • None
Identifiers
  • N-[2-(4-bromo-2,5-dimethoxyphenyl)ethyl]-6-(4-phenylbutoxy)hexan-1-amine
PubChemCID
Chemical and physical data
FormulaC26H38BrNO3
Molar mass492.498 g·mol−1
3D model (JSmol)
  • COC1=CC(=C(C=C1CCNCCCCCCOCCCCC2=CC=CC=C2)OC)Br
  • InChI=1S/C26H38BrNO3/c1-29-25-21-24(27)26(30-2)20-23(25)15-17-28-16-9-3-4-10-18-31-19-11-8-14-22-12-6-5-7-13-22/h5-7,12-13,20-21,28H,3-4,8-11,14-19H2,1-2H3
  • Key:GOUKDEUQBCARRO-UHFFFAOYSA-N

XOB, also known asASR-6001 or asN-[(4-phenylbutoxy)hexyl]-4-bromo-2,5-dimethoxyphenethylamine, is aserotonin5-HT2A receptorantagonist andvoltage-gated sodium channel (VGSC)blocker of thephenethylamine and2C families.[1] It is aderivative of2C-B in which theamine-containingside chain has been extended with the same long group found insalmeterol.[1]

The drug is of relatively lowpotency as a serotonin 5-HT2A receptor antagonist.[1] It shows modestselectivity for the serotonin 5-HT2A receptor over the serotonin5-HT2B and5-HT2C receptors.[1] XOB was accidentally found to havelocal anesthetic properties upon contact with human skin, which led to the elucidation of its sodium channel-blocking activity.[1]

XOB was developed in part by researchers at theAlexander Shulgin Research Institute (ASRI).[1]

See also

[edit]

References

[edit]
  1. ^abcdefDenomme N, Hernandez CC, Bock HA, Ohana RF, Bakshi S, Sherwood AM, McCorvy JD, Daley PF, Callaway WB, Hull JM, Alt A, Isom LL, Cozzi NV (July 2024)."N-(4-Bromo-2,5-Dimethoxyphenethyl)-6-(4-Phenylbutoxy)Hexan-1-Amine (XOB): A Novel Phenylalkylamine Antagonist of Serotonin 2A Receptors and Voltage-Gated Sodium Channels"(PDF).Mol Pharmacol.106 (2):92–106.doi:10.1124/molpharm.123.000837.PMID 38821630.

External links

[edit]


5-HT1
5-HT1A
5-HT1B
5-HT1D
5-HT1E
5-HT1F
5-HT2
5-HT2A
5-HT2B
5-HT2C
5-HT37
5-HT3
5-HT4
5-HT5A
5-HT6
5-HT7
Calcium
VDCCsTooltip Voltage-dependent calcium channels
Blockers
Activators
Potassium
VGKCsTooltip Voltage-gated potassium channels
Blockers
Activators
IRKsTooltip Inwardly rectifying potassium channel
Blockers
Activators
KCaTooltip Calcium-activated potassium channel
Blockers
Activators
K2PsTooltip Tandem pore domain potassium channel
Blockers
Activators
Sodium
VGSCsTooltip Voltage-gated sodium channels
Blockers
Activators
ENaCTooltip Epithelial sodium channel
Blockers
Activators
ASICsTooltip Acid-sensing ion channel
Blockers
Chloride
CaCCsTooltip Calcium-activated chloride channel
Blockers
Activators
CFTRTooltip Cystic fibrosis transmembrane conductance regulator
Blockers
Activators
Unsorted
Blockers
Others
TRPsTooltip Transient receptor potential channels
LGICsTooltip Ligand gated ion channels
Phenethylamines
Amphetamines
Phentermines
Cathinones
Phenylisobutylamines
(and further-extended)
Catecholamines
(and close relatives)
Cyclized
phenethylamines
Phenylalkylpyrrolidines
2-Benzylpiperidines
(phenidates)
Phenylmorpholines
(phenmetrazines)
Phenyloxazolamines
(aminorexes)
Isoquinolines and
tetrahydroisoquinolines
2-Aminoindanes
2-Aminotetralins
Others / unsorted
Related compounds


Stub icon

Thispsychoactive drug-related article is astub. You can help Wikipedia byexpanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=XOB&oldid=1297214506"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2025 Movatter.jp